VALYSTR · Stock research
Listed on NYSE. What the market is pricing into Qiagen N.V. (QGEN) in the Healthcare sector: implied growth, valuation scenarios, SEC-filed financials, and what has moved the stock.
Healthcare · Diagnostics & Research · market value about $10.4B · P/E 25.5 · revenue $2.1B (as of 2026-11-04)
Opening the full page… All companies · Research guides · What a reverse DCF shows